National Health Investors, Inc. (NHI)

National Health Investors Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Rental Revenue	251.99	249.23	217.7	271.05	307.21	294.18
Other Revenue	54.71	49.72	36.68	-1.55	-3.13	-
Total Revenue	329.85	320.39	278.76	297.17	329.69	318.08
Revenue Growth (YoY	6.05%	14.93%	-6.19%	-9.86%	3.65%	7.97%
Property Expenses	11.1	11.51	9.79	11.64	9.65	5.8
Selling, General & Administrative	21.03	19.82	25.32	19.34	14.56	13.91
Depreciation & Amortization	69.87	69.97	70.88	80.8	83.15	76.82
Provision for Loan Losses	-	-	-	-	-	0.06
Other Operating Expenses	41.51	40.04	29.04	0.79	0.53	1.55
Total Operating Expenses	143.5	141.34	135.03	112.56	107.89	98.01
Operating Income	186.35	179.05	143.74	184.61	221.79	220.07
Interest Expense	-59.52	-58.16	-44.92	-50.81	-52.88	-56.3
Other Non-Operating Income	-	0.2	1.11	0.35	-	-
EBT Excluding Unusual Items	126.83	121.09	99.93	134.15	168.91	163.77
Gain (Loss) on Sale of Assets	2.94	14.72	28.34	32.5	21.32	-
Asset Writedown	-0.65	-1.64	-51.56	-51.82	-	-2.5
Other Unusual Items	-3.55	0.21	-11.22	-2.86	-4.92	-0.82
Pretax Income	125.57	134.38	65.5	111.97	185.31	160.45
Earnings From Continuing Operations	125.57	134.38	65.5	111.97	185.31	160.45
Net Income to Company	125.57	134.38	65.5	111.97	185.31	160.45
Minority Interest in Earnings	1.22	1.27	0.9	-0.16	-0.19	0.01
Net Income	126.79	135.65	66.4	111.8	185.13	160.46
Preferred Dividends & Other Adjustments	0.11	0.06	-	-	-	-
Net Income to Common	126.68	135.6	66.4	111.8	185.13	160.46
Net Income Growth	20.21%	104.29%	-40.61%	-39.61%	15.37%	3.97%
Basic Shares Outstanding	43	43	45	46	45	43
Diluted Shares Outstanding	44	43	45	46	45	44
Shares Change (YoY)	0.46%	-3.14%	-2.05%	2.31%	2.28%	3.83%
EPS (Basic)	2.92	3.13	1.48	2.45	4.14	3.70
EPS (Diluted)	2.91	3.13	1.48	2.44	4.14	3.67
EPS Growth	19.94%	111.16%	-39.34%	-41.06%	12.81%	-0.00%
Dividend Per Share	3.600	3.600	3.600	3.803	4.410	4.200
Dividend Growth	0%	0%	-5.33%	-13.78%	5.00%	5.00%
Operating Margin	56.49%	55.88%	51.56%	62.12%	67.27%	69.19%
Profit Margin	38.41%	42.32%	23.82%	37.62%	56.15%	50.45%
Free Cash Flow Margin	61.66%	57.57%	66.49%	70.96%	70.42%	75.75%
EBITDA	256.22	249.02	214.62	265.41	304.94	296.89
EBITDA Margin	77.68%	77.72%	76.99%	89.31%	92.49%	93.34%
D&A For Ebitda	69.87	69.97	70.88	80.8	83.15	76.82
EBIT	186.35	179.05	143.74	184.61	221.79	220.07
EBIT Margin	56.49%	55.88%	51.56%	62.12%	67.27%	69.19%
Funds From Operations (FFO)	191.77	190.37	158.96	211.08	246.18	239.72
FFO Per Share	4.40	4.39	3.55	4.62	5.51	5.49
Adjusted Funds From Operations (AFFO)	-	190.37	158.96	211.08	246.18	239.72
AFFO Per Share	-	4.39	3.55	4.62	5.51	5.49
FFO Payout Ratio	81.51%	82.07%	101.77%	86.65%	79.04%	74.98%
Revenue as Reported	328.89	319.84	278.19	298.72	332.81	318.08

Source: S&P Capital IQ. Real Estate template. Financial Sources.